Fisher & Paykel Healthcare Corporation Limited (FSPKF) has released an update.
Fisher & Paykel Healthcare Corporation Limited has reported a robust start to the 2025 financial year, with strong growth in all products and regions, particularly in its Hospital product group. The company projects first-half revenues to reach between $940 million to $950 million, and net profits after tax to be between $150 million to $160 million, indicating significant growth compared to the previous year. Full-year expectations are also positive, with revenue anticipated to be between $1.9 billion to $2.0 billion and net profit after tax adjusted to a range of $320 million to $370 million.
For further insights into FSPKF stock, check out TipRanks’ Stock Analysis page.
